Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity
Eva Pers Winning Iepsen,
Signe S Torekov
,
Jens Juul Holst
Endocrinology and Metabolism
26
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapies for inter-relating diabetes and obesity - GLP-1 and obesity'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Diabetes
100%
Glucagon-like
100%
Obesity
100%
Pre-diabetes (pre-DM)
28%
Receptor Agonist
28%
A1 Receptor
28%
Weight Reduction
28%
Obesity Diabetes
28%
Incretin
28%
Therapeutic Potential
14%
Obesity Prevalence
14%
Health Care Costs
14%
Obese Men
14%
Type 2 Diabetes Mellitus (T2DM)
14%
Anti-obesity
14%
Non-diabetic Obese
14%
Liraglutide
14%
Public Healthcare
14%
Pharmaceutical Therapy
14%
Clinical Trials
14%
PubMed
14%
Exenatide
14%
Bariatric Surgery
14%
Incretin-based Therapy
14%
Increased Mortality
14%
Satiety
14%
Incretin Hormones
14%
Effective Treatment
14%
Medicine and Dentistry
Glucagon Like Peptide 1
100%
Diabetes
100%
Incretin
80%
Gut
40%
Impaired Glucose Tolerance
40%
Glucagon-Like Peptide-1 Agonist
40%
Drug Therapy
20%
Maturity Onset Diabetes of the Young
20%
Antiobesity Drugs
20%
Liraglutide
20%
Satiety
20%
Diabetic Obesity
20%
Exenatide
20%
Diseases
20%
Bariatric Surgery
20%
Clinical Trial
20%
Prevalence
20%
Public Health
20%
Health Care
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antiobesity Drugs
20%